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We report that the N terminus of the type III secretion system translocator proteins EspB, EspD, and EspA
mediate protein secretion and translocation from wild-type enteropathogenic Escherichia coli and hypersecre-
tion from sepL and sepD mutants. EspA containing the translocation signal of Map and Tir containing the
secretion signal of EspA are biologically active.
Deployment of a type III secretion system (T3SS) is an
infection strategy used by many human pathogens (reviewed in
references 15 and 24). The T3SS is composed of a cytosolic
ATPase, inner and outer membrane rings, and an extracellular
needle. In Yersinia, LcrV forms a distal needle tip structure
(25), while in enteropathogenic Escherichia coli (EPEC) and
enterohemorrhagic E. coli (EHEC), the needle is extended by
long EspA filaments (9, 19). The substrates of the T3SS are
translocator and effector proteins. Translocator proteins of the
Yersinia YopB and YopD family form a translocation pore in
the host cell plasma membrane that enables effector protein
translocation (reviewed in reference 24). Once translocated,
the effectors affect host cell functions, interfering with signaling
pathways and a broad range of physiological processes (re-
viewed in references 14 and 16).
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TABLE 1. E. coli strains and plasmids used in this study
Strain or
plasmid Description Reference Primers used
Strains
E2348/69 Wild-type EPEC O127:H6 22
ICC192 E2348/69 escN 17
ICC305 E2348/69 sepD This study
ICC306 E2348/69 sepL This study
ICC225 E2348/69 tir 2
UMD870 E2348/69espD::aphA3 21
UMD872 E2348/69espA::aphA3 18
Plasmids
pCX340 pBR322 derivative, cloning vector used to fuse genes to blaM, which
encodes the mature form of TEM-1 -lactamase 3
4
pSA10 pKK177-3 derivative containing lacIq gene 28
pICC460 Residues 1 to 20 of EspA fused to TEM-1 This study For-20EspA/Rev-20EspA
pICC492 Residues 1 to 20 of EspB fused to TEM-1 This study For-20EspB/Rev-20EspB
pICC493 Residues 1 to 20 of EspD fused to TEM-1 This study For-20EspD/Rev-20EspD
pICC461 20 random residues fused to TEM-1 This study For-20R/Rev-20R
pICC459 Residues 1 to 20 of EspF fused to TEM-1 This study For-20EspF/Rev-20EspF
pICC285 pSA10 derivative expressing EspA 9
pICC487 pSA10 derivative expressing residues 1 to 20 of Map fused to 20EspA This study Eco-Map-EspA/EspA-PstI
pICC462 Fusion of Map to TEM-1 This study NdeI-MAP-b/MAP-EcoRI
pICC464 Residues 1 to 20 of EspA fused to 20Map-TEM-1 This study NdeI-EspA20MAP/MAP-EcoRI
pICC476 Fusion of Tir to TEM-1 This study F-KpnI-Tir/R-Tir-EcoRI
pICC478 Residues 1 to 20 of EspA fused to 20Tir-TEM-1 This study F-KpnI-EspA20Tir/R-Tir-EcoRI
pICC481 pSA10 derivative expressing Tir, HAa tagged This study Tir-E69-1/Tir-E69-HA
pICC483 pSA10 derivative expressing residues 1 to 20 of EspA fused to 20Tir,
HA tagged
This study EspA20Tir-EcoRI/Tir-E69-HA
a HA, hemagglutinin.
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In EPEC and EHEC, effector protein translocation into
cultured cells leads to the formation of actin-rich pedestal-like
structures at the bacterial attachment sites, which can be visu-
alized by the fluorescent actin staining test (reviewed in refer-
ence 13). The T3SS components in EPEC and EHEC are
encoded within the locus of enterocyte effacement (LEE) (23).
The LEE also encodes gene regulators, chaperones, the trans-
locators EspB and EspD, the EspA filament subunit EspA, and
the effectors Map, EspF, EspG, EspH, EspZ, and Tir (re-
viewed in references 13 and 16).
The fact that the translocators are required for injection of
the effectors suggests the existence of a secretion hierarchy
whereby the former are guided to the secretion apparatus prior
to the latter. A key unanswered question is how this specificity
is achieved (7, 11). An invE mutant of Salmonella (20), a mixC
mutant of Shigella (3), and sepD and sepL mutants of EPEC
(12, 26) are defective for translocator secretion yet oversecrete
effectors. SepD and SepL are LEE-encoded proteins that in-
teract with each other at the bacterial membrane (8, 26). It is
not known how this complex functions, although it might sense
certain environmental signals to switch from the secretion of
translocators to that of effectors (12).
Despite the importance of the T3SS in bacterial pathogen-
esis, the mechanism involved in the recognition of type III
substrates remains poorly understood. Studies conducted over
many years focused on the N-terminal ca. 20-amino-acid se-
cretion signal of the effectors. Indeed, recent studies using
machine-learning approaches have shown that it is possible to
identify T3SS effectors across multiple microorganisms based
on the N-terminal secretion signals (1, 27). Although not able
to provide a consensus secretion signal, these studies identified
sequence biases, conserved structural features, and shared
structural elements. In contrast, very little is currently known
about the N-terminal secretion signals of translocators. In Yer-
sinia, a mutation in the autocleavable protein YscU, YcsUN236A,
did not affect the secretion of effectors but abolished the se-
cretion of YopB, YopD, and LcrV (29). Replacing the N-
terminal secretion signal of LcrV with the first 15 amino acids
of the effector YopE restored secretion and function, which led
the authors to suggest that translocators have a specific N-
terminal secretion signal that is distinct from that of effectors
(29). The aim of this study was to analyze the role of the
N-terminal 20 amino acids of translocators in secretion, trans-
location, and function using EPEC EspA, EspB, and EspD as
model proteins.
We investigated the ability of the N-terminal 20 amino acids
of the translocators EspB (20EspB), EspD (20EspD), and
EspA (20EspA) to mediate the secretion and translocation of
the -lactamase TEM-1 reporter (4). As positive and negative
controls we used TEM fusions with the first 20 residues of the
effector EspF (20EspF) (4) and a random sequence (20R)
derived from the C terminus of maltose binding protein, re-
spectively. In order to construct 20EspA-TEM, 20EspB-TEM,
20EspD-TEM, 20EspF-TEM, and 20R-TEM (the plasmids
TABLE 2. Primers used in this study
Primer Nucleotide sequence
sepL-Kan-fw .....................5-GGTATTGAATTTAATCAAAACCCCGCATCTGTTTTTAATTCTAATTCATTATGTGTAGGCTGGAGCTG
CTTCG-3
sepL-Kan-rv......................5-AACATCCTCCTTATAATCTATCACTTTACCAATCATTAATAATGTATTACTCATATGAATATCCTCCTT
AGTTCC-3
sepD-Cm-fw .....................5-ATGAACAATAATAATGGCATAGCAAAGAATGATTGTGACTGGCTAACGGCCCATATGAATATCCTCC
TTAGTTCC-3
sepD-Cm-rv ......................5-TTACAACAATTCGTCCTATATCAGAAAACAAGTGTGTTGGCGGCATCATTGTTGTGTAGGCTGGAGC
TGCTTCG-3
For-20EspA.........................5-TATGGATACATCAACTACAGCATCAGTTGCTAGTGCGAATGCGAGTACTTCGACATCAATGGAG-3
Rev-20EspA........................5-AATTCTCCATTGATGTCGAAGTACTCGCATTCGCACTAGCAACTGATGCTGTAGTTGATGTATCCA-3
For-20EspB.........................5-TATGAATACTATCGATAATAACAATGCGGCAATCGCAGTTAATTCTGTTTTGAGCAGCACGGAG-3
Rev-20EspB ........................5-AATTCTCCGTGCTGCTCAAAACAGAATTAACTGCGATTGCCGCATTGTTATTATCGATAGTATTCA-3
For-20EspD ........................5-TATGCTTAATGTAAATAACGATATCCAGTCTGTGAGGTCTGGAGCCAGTGCTGCTACGGCTGAG-3
Rev-20EspD........................5-AATTCTCAGCCGTAGCAGCACTGGCTCCAGACCTCACAGACTGGATATCGTTATTTACATTAAGCA-3
For-20R ...............................5-TATGAGCGGTCGTCAGACTGTCGATGAAGCCCTGAAAGACGCGCAGACTCGTATCACCAAGGAG-3
Rev-20R ..............................5-AATTCTCCTTGGTGATACGAGTCTGCGCGTCTTTCAGGGCTTCATCGACAGTCTGACGACCGCTCA-3
For-20EspF .........................5-TATGCTTAATGGAATTAGTAACGCTGCTTCTACACTAGGGCGGCAGCTTGTAGGTATCGCAGAG-3
Rev-20EspF.........................5-AATTCTCTGCGATACCTACAAGCTGCCGCCCTAGTGTAGAAGCAGCGTTACTAATTCCATTAAGCA-3
Eco-Map-EspA...................5-CAGAATTCATGTTTAGTCCAACGGCAATGGTAGGTAGAGCGTTAGCTCAGGCGGTTACACAAACTCT
TGCCTATGATTTAGGGAGCATGT-3
EspA-PstI ............................5-ATTGTCGAAGCTTGGCTGCAGTTATTTACCAAGGGATATTCCTG-3
NdeI-MAP-b.......................5-GGAATAACATATGTTTAGTCCAACGGCAAT-3
MAP-EcoRI........................5-GTGCGAATTCAGCCGAGTATCCTGCACA-3
NdeI-EspA20MAP.............5-GGAATAACATATGGATACATCAACTACAGCATCAGTTGCTAGTGCGAATGCGAGTACTTCGACATCA
ATGAGACCCGCTGTAACCAAGGCTGC-3
F-KpnI-Tir ..........................5-TGGGTACCAAGAAGGAGATATACCATGCCTATTGGTAACCTTGGT-3
R-Tir-EcoRI .......................5-GTGCGAATTCTCAACGAAACGTACTGGTCCCG-3
F-KpnI-EspA20Tir.............5-TGGGTACCAAGAAGGAGATATACCATGGATACATCAACTACAGCATCAGTTGCTAGTGCGAATGCG
AGTACTTCGACATCAATGCCACTACCTTCACAAACAGA-3
Tir-E69-1 .............................5-TGTGAATTCATGCCTATTGGTAACCTTGG-3
Tir-E69-HA.........................5-AAGCGTCGACAGTCGACTTAAGCGTAATCTGGAACATCGTATGGGTATGCACCAACGAAACGTACT
GGTCCCGGCGT-3
EspA20Tir-EcoRI ..............5-ACAGAATTCATGGATACATCAACTACAGCATCAGTTGCTAGTGCGAATGCGAGTACTTCGACATCAA
TGCCACTACCTTCACAAACAGACGG-3
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used are listed in Table 1), the respective primer pairs (Table
2) were annealed and ligated into pCX340 digested with NdeI/
EcoRI. All plasmids were checked by sequencing before they
were transformed into the wild-type and mutant EPEC
E2348/69 strains listed in Table 1.
We expressed the 20EspA-TEM, 20EspB-TEM, and
20EspD-TEM fusions along with control 20R-TEM and
20EspF-TEM fusions in wild-type EPEC strain E2348/69, a
escN (encoding the ATPase) mutant, and sepD and sepL
EPEC mutants (Table 1), which were constructed using the
one-step  red recombination system (10). Briefly, pKD3 and
pKD4 were used as PCR templates to amplify the chloram-
phenicol (sepD) or kanamycin (sepL) resistance gene using
primers containing 50-bp sepD and sepL sequences (Table 2).
The PCR products were electroporated into wild-type EPEC
carrying pKD46, and the mutants were selected on LB plates
with chloramphenicol at 2.5 g/ml or kanamycin at 20 g/ml.
Analysis of proteins secreted into the culture supernatants was
done once the bacterial strains were grown overnight in LB
containing antibiotics at 37°C with shaking. The cultures were
diluted 1/50 in 15 ml Dulbecco’s modified Eagle’s medium
(DMEM; serum free, low glucose [1 g/liter]) and grown at 37°C
at 100 rpm to an optical density at 600 nm (OD600) of 0.4 to
0.5. A 1 mM concentration of isopropyl -D-thiogalactopyr-
anoside (IPTG) was added, and the incubation was continued
for an additional 3 h under the same conditions. Five OD600
units of each culture was centrifuged at 4,000 rpm for 10 min,
and the pellets were resuspended in 1 ml sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) load-
ing buffer. The supernatant was filtered through 0.2-m filters
into Amicon Ultra-15 centrifugal filter devices (UFC 900524;
Millipore) and concentrated to 1 ml. Trichloroacetic acid was
added to a final concentration of 20%, and the samples were
incubated on ice overnight. The samples were then centri-
fuged, washed with cold acetone, and resuspended in 35 l
SDS-PAGE loading buffer. Following gel electrophoresis, the
samples were analyzed by Western blotting using anti-TEM-1
antibody as described previously (4). This showed the compa-
rable expression of all of the TEM fusion proteins in the
different EPEC strains (Fig. 1A). Analyzing the culture super-
FIG. 1. Secretion and translocation of translocator N-terminal sequences fused to TEM. (A) Analysis of whole-cell lysates reveals comparable
expression levels of the TEM fusions in the different EPEC E2348/69 (E69) strains. (B) Secretion profiling reveal that 20EspA, 20EspB, and 20EspD,
but not 20R, can mediate TEM secretion from wild-type EPEC, which was enhanced when the fusions were expressed in the sepD and sepL mutants.
20EspF was included as a positive control. Neither protein was secreted from the escN mutant. Molecular mass markers (in kilodaltons) are indicated
to the left. (C) 20EspA, 20EspB, and 20EspD, but not 20R, mediate TEM protein translocation from wild-type EPEC. 20EspF was included as a positive
control. The data presented are averages of triplicate values obtained from two independent experiments. The statistical significance () of the difference
between E69 and E69escN expressing the indicated TEM fusion (horizontal lines) was determined by Student’s t test.
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natants revealed that 20EspA-TEM, 20EspB-TEM, and
20EspD-TEM were secreted at low levels from wild-type
EPEC compared with the 20EspF-TEM control. However, se-
cretion of the translocator N-terminal TEM fusions from ei-
ther the sepD or the sepL mutant was greatly enhanced com-
pared to secretion from wild-type EPEC (Fig. 1B). The control
20R-TEM was not secreted from any of the strains. Secretion
of all of the TEM fusions from the EPECescN control was
undetectable.
These results show, for the first time, that the N-terminal
sequences of translocators and EspA also contain a signal that
can mediate the secretion of a bystander reporter. Secretion of
TEM by the EspA, EspB, and EspD signals is specific, as a
random sequence did not allow protein secretion. These re-
sults are different from those reported by Chiu et al. (5), who
showed that the first 21 amino acids of EspB from EHEC do
not mediate the secretion of a reporter. The apparent dis-
agreement could be due to the different reporter protein em-
ployed, the detection sensitivity, or the fact that the sequences
of the first 20 amino acids of the EPEC and EHEC EspB
proteins are only 55% identical. Nonetheless, our results sug-
gest that the SepL/D complex functions as a checkpoint assess-
ing N-terminal secretion signals and/or recognizes downstream
translocator sequences.
Next we investigated if the 20EspA-TEM, 20EspB-TEM,
and 20EspD-TEM fusions are translocated into HeLa cells.
20R-TEM and 20EspF-TEM fusions were used as negative
and positive controls, respectively. Cultures of wild-type
EPEC, the escN mutant, or espD mutant strain UMD870
(Table 1), which served as an additional negative control (sepD
and sepL mutants were not analyzed, as they are deficient in
protein translocation), expressing each of the TEM fusions
were primed in DMEM for 3 h, conditions that are conducive
to LEE gene expression (6), prior to the infection of HeLa
cells. After 90 min, the cells were washed, the -lactamase
substrate CCF2/AM was added, and the cultures were incu-
bated for an additional 90 min as previously described (4).
Translocation was expressed as the emission ratio at 447/520
nm to normalize the -lactamase activity.
20EspA-TEM, 20EspB-TEM, and 20EspD-TEM were
translocated into HeLa cells from wild-type EPEC, albeit at
lower efficiency than 20EspF-TEM. The translocation effi-
ciency order of the different TEM fusions was 20EspA 
20EspB  20EspD  20EspF. The control 20R-TEM was not
translocated. Neither protein was translocated from the escN
(Fig. 1C) or espD (data not shown) negative control. These
results show, also for the first time, that the N-terminal secre-
tion signal of translocators, when expressed in the context of a
reporter, can mediate protein translocation.
We next investigated the specificity of the N-terminal secre-
tion signal of EspA. Toward this end, we generated a version
of pSA10 expressing native EspA (9) in which 20EspA was
replaced with the first 20 residues of Map (20Map). The gene
encoding EspA was amplified by PCR (the primers used are
listed in Table 2) using EPEC strain E2348/69 genomic DNA
as a template with Pfu polymerase. The resulting PCR product
was digested with EcoRI/PstI, cloned into pSA10, and trans-
formed into host strains. We first analyzed protein secretion
from espA mutant EPEC strain UMD872 (Table 1) comple-
mented with a plasmid encoding wild-type EspA and 20Map-
EspA. As SepD and SepL are essential for the secretion of
translocators but not effectors (12, 26), we also analyzed the
secretion profile from the sepD and sepL mutants. EPECescN
was used as a negative control. EspA was detected by Western
blotting with rabbit polyclonal EPEC EspA antiserum (19),
followed by anti-rabbit peroxidase conjugate (Sigma) as a sec-
ondary antibody. Western blot analysis confirmed that the
EspA variants are expressed in these host strains (Fig. 2A, top
panel). Native EspA and 20Map-EspA were secreted from
UMD872 but not from the control escN mutant strain (Fig.
FIG. 2. 20Map can replace the secretion signal of EspA. (A, top panel) Shown are comparable protein expression levels in whole-cell lysates
of the different EPEC E2348/69 (E69) strains. (A, bottom panel) Native EspA is secreted from EPECespA (UMD872) but not from the escN,
sepD, and sepL mutants, while 20Map-EspA is secreted from UMD872 and sepD and sepL mutants. Molecular mass markers (in kilodaltons) are
indicated to the left. (B) 20Map-EspA is biologically active, as judged by its ability to complement an espA mutant in terms of actin polymerization
at the bacterial attachment sites. Actin was labeled using Oregon Green-conjugated phalloidin.
VOL. 192, 2010 NOTES 3537
 o
n
 June 20, 2018 by LO
NDO
N SCHO
O
L O
F HYG
IENE & TRO
PICAL M
EDICINE
http://jb.asm.org/
D
ow
nloaded from
 
2A, bottom panel). Importantly, while native EspA was not
secreted from the sepD or sepL mutant, 20Map-EspA was
secreted by both mutant strains (Fig. 2A, bottom panel). These
results show that when the secretion signal of EspA is replaced
with 20Map it gains partial effector characteristics.
We investigated if 20Map-EspA is biologically active. To-
ward this end, Swiss mouse 3T3 cells were infected with primed
EPEC UMD872 expressing EspA, 20Map-EspA, or the empty
vector pSA10. After 3 h of infection, cells were washed, fixed
with paraformaldehyde, and stained for immunofluorescence
microscopy with Oregon Green-conjugated phalloidin (In-
vitrogen) and 0.1% 4,6-diamidino-2-phenylindole (DAPI) di-
luted in phosphate-buffered saline (PBS)-donkey serum (Jack-
son ImmunoResearch) for 45 min. Cells were washed three
times with PBS, mounted in Dako mountain medium, and
examined by conventional epifluorescence microscopy using a
Zeiss Axio Imager microscope. 20Map-EspA restored the abil-
ity of UMD872 to trigger actin polymerization as a marker of
protein translocation to the same extent as native EspA (Fig.
2B). These results are consistent with the data of Sorg et al.
(29) that showed that the 15 amino acids of YopE are func-
tionally exchangeable with the N-terminal amino acids of
LcrV.
We investigated if the secretion signal of an effector is ex-
changeable with that of EspA. Toward this end, we replaced
the N-terminal secretion signals of Tir and Map with 20EspA.
The genes encoding Tir and Map were amplified by PCR (the
primers used are listed in Table 2) using E2348/69 genomic
DNA as the template. The resulting PCR products were di-
gested with KpnI/EcoRI or NdeI/EcoRI (for tir and map, re-
spectively), cloned into the same restriction sites in pCX340,
and transformed into the wild-type and mutant E2348/69
strains. Analysis of whole-cell extracts revealed that replacing
the native secretion signal sequences with 20EspA did not
affect protein expression levels or stability (data not shown).
Analyzing the secretion profiles has shown that the native
effector-TEM fusions were secreted from wild-type EPEC but
not from the escN mutant (Fig. 3A). Secretion of native
Tir-TEM, but importantly not of Map-TEM, from the sepD
and sepL mutants was dramatically enhanced (Fig. 3A).
20EspA-Map and 20EspA-Tir fusions were secreted at low
levels from wild-type EPEC, but enhanced secretion from the
sepD and sepL mutants was observed. For reasons that are
currently not known, secretion of 20EspA-Map was particu-
larly enhanced when it was expressed in the sepD and sepL
mutants (Fig. 3A).
In order to determine if 20EspA-Map and 20EspA-Tir are
translocated into HeLa cells, they were expressed in wild-
type EPEC; the escN and espD mutants were used as
negative controls. 20EspA-Map and 20EspA-Tir were trans-
located from wild-type EPEC, while no translocation from
EPECescN (Fig. 3B) or EPECespD (data not shown) was
FIG. 3. Secretion and translocation of native and 20EspA-Map/
Tir-TEM fusions. (A) Native Map and Tir and 20EspA-Map and
20EspA-Tir fused to TEM were secreted from wild-type EPEC
E2348/69 (E69); enhanced secretion of native Tir, 20EspA-Map, and
20EspA-Tir from the sepD and sepL mutants was detected. Neither
protein was secreted from the escN mutant. Molecular mass markers
(in kilodaltons) are indicated to the left. (B) A translocation assay
using wild-type EPEC revealed that 20EspA enhanced the transloca-
tion of Map, while the translocation of 20EspA-Tir remained at the
same levels as that of native Tir. Neither effector was translocated from
the escN mutant. The data presented are averages of triplicate values
obtained from two independent experiments. The statistical signifi-
cance () of the difference between E69 and E69escN expressing the
indicated TEM fusion (horizontal lines) was determined by Student’s
t test.
FIG. 4. 20EspA-Tir is biologically active. EPECtir containing
pSA10 encoding native Tir or 20EspA-Tir, but not the empty vector,
triggers actin polymerization in infected Swiss mouse 3T3 cells. Actin
was labeled using Oregon Green-conjugated phalloidin.
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detected. Interestingly, compared with the native secretion sig-
nal, 20EspA enhanced the translocation efficiency of Map (Fig.
3B) while translocation of 20EspA-Tir remained at the same
levels as that of native Tir.
Finally, we tested if 20EspA fused to an effector can mediate
protein translocation by expressing 20EspA-Tir in EPECtir.
However, as the Tir-TEM fusion did not complement
EPECtir (data not shown), we generated a pSA10 derivative
encoding 20EspA-Tir; native Tir and the empty vector were
used as controls (the primers used are listed in Table 2).
Infection of Swiss mouse 3T3 cells with primed bacteria has
shown that while the empty pSA10 vector was unable to com-
plement EPECtir, both native Tir and 20EspA-Tir comple-
mented the mutant, as measured by the ability of the strains to
trigger actin polymerization at the bacterial attachment sites
(Fig. 4).
In conclusion, our data show that the N termini of translo-
cators (EspB and EspD) and a structural needle tip protein
(EspA) contain an N-terminal secretion signal that, when ex-
pressed in the context of a reporter or an effector, can mediate
protein translocation.
We thank Mona Singh and Navjyot Sangha for preliminary data.
This project was supported by the Wellcome Trust.
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